Type 2 Diabetes

Rising Insulin Prices: ADA & Endocrine Society Call for Action

Rising Insulin Prices: ADA & Endocrine Society Call for Action

By

The American Diabetes Association and the Endocrine Society have issued statements with the intent of improving insulin access and affordability.

Adiponectin Independently Associated With Increased Mortality in Diabetics

Adiponectin Independently Associated With Increased Mortality in Diabetics

Further study is required to understand the complex relationship between adiponectin and cardiovascular outcomes in type 2 diabetes with ACS.

GLP-1RA Therapy Plus Exercise for Management of Dysregulated Type 2 Diabetes

GLP-1RA Therapy Plus Exercise for Management of Dysregulated Type 2 Diabetes

GLP-1RA therapy may limit the benefit of exercise on patients with dysregulated type 2 diabetes, according to research.

Benefits of Sustained Weight Loss in Type 2 Diabetes

Benefits of Sustained Weight Loss in Type 2 Diabetes

Over 5 years follow-up, researchers found reduced levels of HbA1c, triglycerides, LDL-cholesterol, and quality of life in patients who reported sustained weight loss.

Addition of Bariatric Surgery to Intensive Medical Therapy More Effective at Resolving T2D Hyperglycemia

Addition of Bariatric Surgery to Intensive Medical Therapy More Effective at Resolving T2D Hyperglycemia

By

Bariatric surgery improved outcomes in weight, triglycerides, HDL cholesterol, and quality of life compared with intensive medical therapy alone.

Diabetes Psychosocial Care Addressed by ADA in First Published Recommendations

Diabetes Psychosocial Care Addressed by ADA in First Published Recommendations

By

Evidence-based guidelines and clinician recommendations have been evaluated to create the first-of-its-kind statement focused on psychosocial care of people with diabetes.

Case Study: Combination GLP-1/DPP-4 Therapy in Type 2 Diabetes

Case Study: Combination GLP-1/DPP-4 Therapy in Type 2 Diabetes

By

The use of combined GLP-1/DPP-4 medication therapy is not currently supported by American Diabetes Association guidelines.

Diabetic Neuropathy: Updated ADA Position Statement

Diabetic Neuropathy: Updated ADA Position Statement

By

The ADA updated recommendations on prevention methods and pain management for 2 forms of diabetic neuropathy.

Low Vitamin B12 Levels Associated With Long-Term Metformin Use

Low Vitamin B12 Levels Associated With Long-Term Metformin Use

By

Researchers found that those at risk for low vitamin B12 levels are often not properly monitored.

Insulin Resistance Impacted by Circulating Extracellular RNAs

Insulin Resistance Impacted by Circulating Extracellular RNAs

Eighteen extracellular RNAs were linked to insulin resistance across age-, sex-, and BMI-adjusted models.

Metabolic Response in Animal vs Plant Protein-Based Diets

Metabolic Response in Animal vs Plant Protein-Based Diets

While the metabolic responses to each diet were different, both diets improved patient's cardiovascular disease risk factors.

Dulaglutide Approved for Use in Combination With Basal Insulin

Dulaglutide Approved for Use in Combination With Basal Insulin

By

The labeling for Trulicity (dulaglutide; Eli Lilly) has been updated to include use in combination with basal insulin for adults with type 2 diabetes, following approval from the Food and Drug Administration (FDA).

Snus Consumption Identified as Risk Factor for Type 2 Diabetes

Snus Consumption Identified as Risk Factor for Type 2 Diabetes

Data was pooled for 5 cohorts to study the association between smokeless tobacco use and risk of type 2 diabetes development.

Does Air Pollution Exposure Up Type 2 Diabetes Risk?

Does Air Pollution Exposure Up Type 2 Diabetes Risk?

The presence of nitrogen dioxide and particulate matter were both linked to an increased risk of type 2 diabetes in Los Angeles-area Hispanic children.

New Or Rapidly Deteriorating Type 2 Diabetes May Be Indicative of Pancreatic Cancer

New Or Rapidly Deteriorating Type 2 Diabetes May Be Indicative of Pancreatic Cancer

Newly developing or rapidly worsening type 2 diabetes may be a signal of early pancreatic cancer, according to research presented at ECCO 2017.

Injection-Free GLP-1 Receptor Agonist for T2D Under FDA Review

Injection-Free GLP-1 Receptor Agonist for T2D Under FDA Review

By

The Food and Drug Administration has accepted a New Drug Application for ITCA 650 (Intarcia Therapeutics) for further review in patients with type 2 diabetes.

HbA1c May Underestimate Glycemic Control in Blacks With Sickle Cell Trait

HbA1c May Underestimate Glycemic Control in Blacks With Sickle Cell Trait

The relationship between sickle cell train and hemoglobin A1c for given levels of fasting or 2-hour glucose levels among African Americans was evaluated in a retrospective cohort study.

Bariatric Surgery Improves Splanchnic Vascular Responses in Type 2 Diabetes

Bariatric Surgery Improves Splanchnic Vascular Responses in Type 2 Diabetes

For obese patients with type 2 diabetes, bariatric surgery is associated with improved splanchnic vascular responses.

Elevated Aspirin Nonresponsiveness in Type 2 Diabetes

Elevated Aspirin Nonresponsiveness in Type 2 Diabetes

By

Researchers set out to determine whether or not aspirin therapy in type 2 diabetes is effective.

Bariatric Surgery May Prevent Diabetic Retinopathy

Bariatric Surgery May Prevent Diabetic Retinopathy

There are fewer cases of incident diabetic retinopathy among obese patients with type 2 diabetes undergoing bariatric surgery compared with medical treatment.

Combination Exenatide, Pioglitazone Beneficial in Type 2 Diabetes

Combination Exenatide, Pioglitazone Beneficial in Type 2 Diabetes

By

Patients with type 2 diabetes that is uncontrolled on metformin plus a sulfonylurea may benefit from combination therapy with a GLP-1 receptor agonist and pioglitazone.

Anxiety Increased Mortality Risk in Type 2 Diabetes

Anxiety Increased Mortality Risk in Type 2 Diabetes

For individuals with type 2 diabetes, anxiety symptoms affect mortality risk, independently of depression symptoms, and attenuate the excess mortality associated with depression.

Cardiovascular Risk With Sitagliptin in Older Patients With Type 2 Diabetes

Cardiovascular Risk With Sitagliptin in Older Patients With Type 2 Diabetes

Sitagliptin has a neutral effect on cardiovascular risk among older patients with type 2 diabetes.

Type 2 Diabetes Associated With Some Apolipoproteins

Type 2 Diabetes Associated With Some Apolipoproteins

Apolipoprotein (apo) CIII and apoCIII-to-apoA1 ratio are correlated with incident type 2 diabetes.

Type 2 Diabetes Risk Tied to Omega-3 Fatty Acid Consumption

Type 2 Diabetes Risk Tied to Omega-3 Fatty Acid Consumption

Consumption of single omega-3 is associated with an increased risk of type 2 diabetes, with dosage, ethnicity, trial duration, and recruited age influencing the effect.

Adipose Tissue Insulin Resistance Increased in Obese Patients

Adipose Tissue Insulin Resistance Increased in Obese Patients

Resistance to the antilipolytic effect of insulin is increased in obese individuals with normal glucose tolerance, and in those with impaired glucose tolerance and type 2 diabetes.

<i>Lactobacillus</i> Supplement Did Not Affect HbA1c in Type 2 Diabetes

Lactobacillus Supplement Did Not Affect HbA1c in Type 2 Diabetes

Patients receiving the highest dose of L. reuteri have increases in insulin sensitivity index vs baseline.

SGLT2 Inhibitor Effective With Low-Carb, High-Carb Diet in Type 2 Diabetes

SGLT2 Inhibitor Effective With Low-Carb, High-Carb Diet in Type 2 Diabetes

For patients with type 2 diabetes, the SGLT2 inhibitor luseogliflozin has similar efficacy when meals contain 40% to 55% total energy from carbohydrate.

ACP Issues New Guideline for Oral Pharmacologic Treatment of Type 2 Diabetes

ACP Issues New Guideline for Oral Pharmacologic Treatment of Type 2 Diabetes

By

The ACP has updated the 2012 guideline to provide clinical recommendations of oral pharmacologic treatment of type 2 diabetes.

Postprandial Hyperglycemia Associated With CVD in Type 2 Diabetes

Postprandial Hyperglycemia Associated With CVD in Type 2 Diabetes

Postprandial hyperglycemia is linked to cardiovascular disease in patients with type 2 diabetes, regardless of HbA1c.

Sign Up for Free e-Newsletters